WO2002044131A1 - Dérivés d'acide carboxylique substitués - Google Patents
Dérivés d'acide carboxylique substitués Download PDFInfo
- Publication number
- WO2002044131A1 WO2002044131A1 PCT/JP2001/010354 JP0110354W WO0244131A1 WO 2002044131 A1 WO2002044131 A1 WO 2002044131A1 JP 0110354 W JP0110354 W JP 0110354W WO 0244131 A1 WO0244131 A1 WO 0244131A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carboxylic acid
- acid derivatives
- substituted carboxylic
- dotted line
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002222551A AU2002222551A1 (en) | 2000-11-29 | 2001-11-28 | Substituted carboxylic acid derivatives |
JP2002546501A JPWO2002044131A1 (ja) | 2000-11-29 | 2001-11-28 | 置換カルボン酸誘導体 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-363678 | 2000-11-29 | ||
JP2000363678 | 2000-11-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002044131A1 true WO2002044131A1 (fr) | 2002-06-06 |
Family
ID=18834749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2001/010354 WO2002044131A1 (fr) | 2000-11-29 | 2001-11-28 | Dérivés d'acide carboxylique substitués |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2002044131A1 (fr) |
AU (1) | AU2002222551A1 (fr) |
WO (1) | WO2002044131A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015046317A1 (fr) * | 2013-09-30 | 2015-04-02 | 国立大学法人岡山大学 | Nouveau dérivé d'acétylène-amide |
JP2018524353A (ja) * | 2015-07-02 | 2018-08-30 | ザ メディカル カレッジ オブ ウィスコンシン インクThe Medical College Of Wisconsin, Inc. | 可溶性エポキシド加水分解酵素およびペルオキシソーム増殖活因子活性化受容体の新規な二重調節因子を用いた糖尿病およびメタボリックシンドロームの治療 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000256194A (ja) * | 1999-01-06 | 2000-09-19 | Mitsui Chemicals Inc | 核内レセプタ作動薬およびその効果増強剤 |
WO2000075103A1 (fr) * | 1999-06-09 | 2000-12-14 | Kyorin Pharmaceutical Co., Ltd. | DERIVES D'ACIDE PHENYLPROPIONIQUE SUBSTITUES COMME AGONISTES DU RECEPTEUR HUMAIN ACTIVE DE LA PROLIFERATION DES PEROXYSOMES (PPAR) $g(a) |
WO2001025181A1 (fr) * | 1999-10-01 | 2001-04-12 | Eisai Co., Ltd. | Derives d'acide carboxylique et medicaments les contenant |
-
2001
- 2001-11-28 WO PCT/JP2001/010354 patent/WO2002044131A1/fr active Application Filing
- 2001-11-28 AU AU2002222551A patent/AU2002222551A1/en not_active Abandoned
- 2001-11-28 JP JP2002546501A patent/JPWO2002044131A1/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000256194A (ja) * | 1999-01-06 | 2000-09-19 | Mitsui Chemicals Inc | 核内レセプタ作動薬およびその効果増強剤 |
WO2000075103A1 (fr) * | 1999-06-09 | 2000-12-14 | Kyorin Pharmaceutical Co., Ltd. | DERIVES D'ACIDE PHENYLPROPIONIQUE SUBSTITUES COMME AGONISTES DU RECEPTEUR HUMAIN ACTIVE DE LA PROLIFERATION DES PEROXYSOMES (PPAR) $g(a) |
WO2001025181A1 (fr) * | 1999-10-01 | 2001-04-12 | Eisai Co., Ltd. | Derives d'acide carboxylique et medicaments les contenant |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015046317A1 (fr) * | 2013-09-30 | 2015-04-02 | 国立大学法人岡山大学 | Nouveau dérivé d'acétylène-amide |
JP2018524353A (ja) * | 2015-07-02 | 2018-08-30 | ザ メディカル カレッジ オブ ウィスコンシン インクThe Medical College Of Wisconsin, Inc. | 可溶性エポキシド加水分解酵素およびペルオキシソーム増殖活因子活性化受容体の新規な二重調節因子を用いた糖尿病およびメタボリックシンドロームの治療 |
Also Published As
Publication number | Publication date |
---|---|
AU2002222551A1 (en) | 2002-06-11 |
JPWO2002044131A1 (ja) | 2004-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102435676B1 (ko) | 독성 알데히드 관련된 질병 및 치료 | |
CA2445145A1 (fr) | Derives d'oxazole substitues par de l'acide carboxylique utiles en tant qu'activateurs ppar-alpha et gamma dans le traitement du diabete | |
CA2376094A1 (fr) | Derives d'acide phenylpropionique substitues comme agonistes du recepteur humain active de la proliferation des peroxysomes (ppar) .alpha. | |
EP1690538A4 (fr) | Derive d'isoxazole presentant un effet agoniste sur le recepteur active par les proliferateurs des peroxysomes | |
HK1075660A1 (en) | Polycyclic compounds as potent alpha2-adrenoceptorantagonists | |
NZ514661A (en) | alpha-substituted carboxylic acid derivatives and their use as therapeutic agents in pharmaceutical compositions | |
WO2003002593A3 (fr) | Structures peptidiques utiles pour la modulation competitive de la catalyse de dipeptidyle peptidase iv | |
RS50140B (sr) | Postupak za dobijanje perkihinina i njegova upotreba | |
EP1312601A4 (fr) | Derives d'acide carboxylique, procede de production de ceux-ci et medicaments contenant ceux-ci comme principe actif | |
TW200716572A (en) | Peroxisome proliferator activated receptor alpha agonists | |
MY139475A (en) | Process for the preparation of (1s)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane, acid addition salts thereof and its use for the synthesis of ivabradine and for its pharmaceutically acceptable acid addition salts | |
WO2002044127A1 (fr) | Dérivés d'acide carboxylique substitué | |
WO2003044015A3 (fr) | Acides heteroarylalkanoiques substitues | |
JO2493B1 (en) | New phenyl azatidinone with improved physical properties and methods of preparation of drugs containing it and its uses | |
WO2002085861A8 (fr) | Composes d'imidazolidine et leur utilisation comme antagonistes de cxcr3 | |
EP1348698A4 (fr) | Derives de l'acide carboxylique substitues | |
WO2003048130A3 (fr) | Agonistes du recepteur active de proliferation du peroxisome | |
PL316563A1 (en) | Application of derivatives of carboxylic acids as therapeutic agents | |
WO2002044130A1 (fr) | Dérivés d'acide carboxylique substitués | |
WO2002044131A1 (fr) | Dérivés d'acide carboxylique substitués | |
WO2003022280A3 (fr) | 3-glyoxlylamide-indoles pour traitement du cancer | |
AU7096096A (en) | Indole derivatives and medical application thereof | |
WO2003087040A3 (fr) | Mimiques d'acyl-coenzyme a comprenant des derives de pantolactone et d'acide pantothenique, leurs compositions, methodes de regulation du taux de cholesterol et utilisations associees | |
EP1390343A4 (fr) | Nouveaux derives de retinoide, procedes de preparation de ces composes et composition pharmaceutique anti-cancer renfermant lesdits composes | |
AU5243293A (en) | Nonatetraenoic acid derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002546501 Country of ref document: JP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |